Financial hardship common among colon cancer patients

March 13, 2012
Financial hardship common among colon cancer patients

(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March 12 in the Journal of Clinical Oncology.

Veena Shankaran, M.D., of the University of Washington in Seattle, and colleagues conducted a study involving 555 patients with stage III , during or following adjuvant chemotherapy, who were identified using data from a population-based cancer registry. In an effort to identify those who experienced financial hardship as a direct result of their illness, participants completed a survey detailing their treatment-related costs, accrued debt, whether they were forced to sell assets or borrow money, or if they had experienced a decline in income.

The researchers found that nearly all of the 51.2 percent of patients who responded were insured during their colon cancer treatment. Overall, 38 percent reported some type of financial hardship as a consequence of their cancer treatment. Younger people and those with lower annual household incomes were more likely to report financial hardship. The factors most closely associated with treatment non-adherence were younger age, lower income, and unemployment or disability (which usually occurred following diagnosis).

"A significant proportion of patients undergoing adjuvant chemotherapy for stage III colon cancer may experience , despite having . Interventions to help at-risk patients early on during therapy may prevent long-term financial adverse effects," the authors write.

Explore further: Gene signature may improve colon cancer treatment

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

Gene signature may improve colon cancer treatment

February 26, 2010

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

Complementary meds used by 17 percent of elderly with cancer

March 2, 2012

(HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional status, according ...

Recommended for you

Oxygen can impair cancer immunotherapy in mice

August 25, 2016

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers. This mechanism involves oxygen inhibition of the anticancer ...

Stem cell propagation fuels cancer risk in different organs

August 25, 2016

The idea that stem cells - special cells that divide to repair and generate tissues - might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.